Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Correction: NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancerFeng, Linyuan ; Yang, Yang ; Lin, Zhenhua ; Cui, Minghua ; Jin, Aihua ; Cui, AiliGenes and environment, 2024-02, Vol.46 (1), p.6-6, Article 6 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapyHuang, Qian ; Xi, Jiajia ; Wang, Lei ; Wang, Xu ; Ma, Xiaodong ; Deng, Qipan ; Lu, Yong ; Kumar, Munish ; Zhou, Zhiyuan ; Li, Ling ; Zeng, Zhaoyang ; Young, Ken H ; Yi, Qing ; Zhang, Mingzhi ; Li, YongJournal of hematology and oncology, 2018-07, Vol.11 (1), p.90-90, Article 90 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicityBol, Kees ; Marissen, Wilfred ; Elaissais-Schaap, Jeroen ; Tacken, Paul ; Engels, Steef ; Wang, Liang-Chuan ; Mondal, Arpita ; Throsby, Mark ; Roberts, Alan ; Mayes, Patrick ; Geuijen, CecileJournal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A863-A863 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
564 Potency-reduced and extended half-life IL12 heterodimeric Fc-fusions exhibit strong anti-tumor activity with potentially improved therapeutic index compared to native IL12 agentsBernett, Matthew ; Varma, Rajat ; Liu, Ke ; Bonzon, Christine ; Rashid, Rumana ; Rodriguez, Nicole ; Hassanzadeh-Kiabi, Nargess ; Ardila, Connie ; Chu, Seung ; Muchhal, Umesh ; Desjarlais, JohnJournal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A598-A598 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
237 In vitro potency assays for immune checkpoint blockade using human primary cells, murine huGEMM immune cells and patient-derived tumor organoidsYan, Xuefei ; Zhang, Hongjuan ; Zhou, Jun ; Zheng, Jia ; Zhu, Shuang ; Zhang, Rui ; Zang, Mingfa ; An, Annie Xiaoyu ; Xu, Xiaoxi ; Wang, Shuzong ; Xu, Kevin Qijin ; Ouang, Davy Xuesong ; Li, Henry ; Huang, YujunJournal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A254-A254 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
40 The orion™ platform from rarecyte® enables same-day 21-plex fluorescence tissue analysisCampton, Daniel ; Cooper, Jeremy ; Reese, Steven ; Teplitz, Kyla ; Werbin, Jeffrey ; Nordberg, Joshua ; Kaldjian, Eric ; George, TadJournal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A41-A41 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Correction to: Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T-cell immunityTchekneva, Elena E ; Goruganthu, Mounika U L ; Uzhachenko, Roman V ; Thomas, Portia L ; Antonucci, Anneliese ; Chekneva, Irina ; Koenig, Michael ; Piao, Longzhu ; Akhter, Anwari ; de Aquino, Maria Teresa P ; Ranganathan, Parvathi ; Long, Nicholas ; Magliery, Thomas ; Valujskikh, Anna ; Evans, Jason V ; Arasada, Rajeswara R ; Massion, Pierre P ; Carbone, David P ; Shanker, Anil ; Dikov, Mikhail MJournal for immunotherapy of cancer, 2019-05, Vol.7 (1), p.124-124, Article 124 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Author Correction: Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapyYu, Yuanhuan ; Wu, Xin ; Wang, Meiyan ; Liu, Wenjing ; Zhang, Li ; Zhang, Ying ; Hu, Zhilin ; Zhou, Xuantong ; Jiang, Wenzheng ; Zou, Qiang ; Cai, Fengfeng ; Ye, HaifengNature communications, 2024-05, Vol.15 (1), p.3686-3686, Article 3686 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Abstract withdrawnJournal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A471-A471 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Current progress in NK cell biology and NK cell-based cancer immunotherapyTarazona, Raquel ; Lopez-Sejas, Nelson ; Guerrero, Beatriz ; Hassouneh, Fakhri ; Valhondo, Isabel ; Pera, Alejandra ; Sanchez-Correa, Beatriz ; Pastor, Nieves ; Duran, Esther ; Alonso, Corona ; Solana, RafaelCancer Immunology, Immunotherapy, 2020-05, Vol.69 (5), p.879-899 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |